Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$16,000
Est. net congressional buying / selling (2 years). Updated Oct 9, 2026

Are Members of Congress Buying or Selling Moderna?

2 members of the U.S. Congress have traded Moderna (MRNA) stock in the past 90 days, across 2 buys and 1 sell. Congressional trades are reported under the STOCK Act and are typically disclosed within 45 days of the transaction.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the MRNA AI Score. For corporate insider activity, see MRNA insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading Moderna?

Member of CongressActivityTradesLast Trade
Ro Khanna Bought $16,000 2 Sep 11, 2026
Maria Elvira Salazar Mixed $16,000 2 Sep 24, 2026
Julie Johnson Sold $8,000 1 Jan 15, 2025
Rob Bresnahan Bought $8,000 1 Feb 25, 2025

MRNA Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
Maria Elvira Salazar Sep 24, 2026 Sell $1K – $15K
Ro Khanna Sep 11, 2026 Buy $1K – $15K
Maria Elvira Salazar Aug 19, 2026 Buy $1K – $15K
Ro Khanna Jul 25, 2025 Buy $1K – $15K
Rob Bresnahan Feb 25, 2025 Buy $1K – $15K
Julie Johnson Jan 15, 2025 Sell $1K – $15K

Frequently Asked Questions: Moderna Congress Trading

In the past 90 days, members of Congress have made 2 purchases and 1 sale of MRNA stock. The net buying may reflect confidence in the stock. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

Maria Elvira Salazar sold Moderna (MRNA) stock most recently, on September 24, 2026.

The estimated net value of congressional trades in Moderna over the past 2 years is positive, at $16,000, meaning members of Congress have on balance bought more than they have sold.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.